MedSource Management Team
- Chris Clark
Chief Financial Officer
- Matthew Wagener
Director of Corporate Operations and Development
- Lora Iversen
- Associate Director, Field Operations
- Jennifer Delaney
Associate Director, Contracts & Finance
- Marcia Phillips
- Quality Assurance Manager
Eric Lund, President & CEO
Eric Lund is the founder and CEO of MedSource. Since 1997, Mr. Lund has directed the growth and success of MedSource as the company created definitive solutions for serving the research community. Since its inception, the company has steadily expanded with offices now in Houston, Raleigh and San Diego and plans are set to open a location in Boston in 2015.
Mr. Lund has more than 20 years of experience in the biopharmaceutical industry at all levels of management. Under his leadership and direction, MedSource has grown into a full-service CRO known for its oncology expertise and quality services. It has been recognized several times by Inc. 500 and the Houston 100 as one of the fastest growing privately held companies and has also been an Eli Lilly Quality Advocate Award winner. Most recently, MedSource was given a CRO Leadership Award by Life Science Leader magazine.
Mr. Lund is a member of numerous industry organizations and currently serves on the Board of Trustees at Malone University.
Chris Clark, Chief Financial Officer
Chris Clark joined Medsource in April 2016 as Chief Financial Officer and has overall responsibility for Finance, HR and IT.
Prior to joining Medsource, Chris spent the previous 6 years in senior financial leadership roles within the CRO sector, where he was instrumental in growing, selling and integrating two niche CROs (Nexus Oncology Ltd to Ockham in 2012; and Ockham to Chiltern International Ltd in 2014).
As CFO of North America for Chiltern, Chris had dual responsibility for the strategic direction and operations of the global staffing division and the North American finance function, in addition to playing a leading role in the acquisition and integration of Theorem Clinical Research, in the latter part of 2015.
Chris trained with Ernst & Young in the early part of his career before joining Ardana plc, a start-up specialty pharmaceutical business in 2003 where he supported the company through a number of private funding rounds and helped oversee the company's successful listing on the London Stock Exchange in 2005.
Chris graduated from the University of Aberdeen, UK with a Masters in Economics and Management Studies. He is currently located in the UK office, in Edinburgh.
Matthew Wagener, Director of Corporate Operations & Development
Matthew joined MedSource in 2013 as the Director of Corporate Operations & Development where his responsibilities span corporate and business operations functions including key areas of business development, marketing, strategic planning, technology development, as well as oversight of facilities management, human resources, and quality assurance. Prior to joining MedSource, Matthew came from McKesson/US Oncology where he held several management positions in operations and business development and led the launch and management of their CRO business unit.
Prior to managing the CRO business unit, he directed clinical research development for the Lung, GI, Hematology, and Radiation Oncology research programs. He has also held other research positions at the University of Texas Medical Branch in Galveston in the department of Orthopedic Surgery and MD Anderson Cancer Center in the department of Radiation Oncology. Matthew received his degree in biomedical science from Texas A&M University. Since starting his career in research, he has worked in key sections of basic and clinical research from bench to bedside to management.
Lora Iversen, Associate Director, Field Operations
Lora Iversen joined MedSource in February 2012 and serves as the Field Operations Manager. She currently oversees the CRA resourcing and monitoring teams at MedSource and has additional responsibilities in in client and project management. Lora also participates in the development and implementation of operational strategies and policies and procedures for the Clinical Operations Department.
Prior to MedSource, she spent 12 years at Novartis Pharmaceuticals as Expert CRA and Team Leader where she had key responsibilities for clinical monitoring, global lead CRA, monitoring plan review, training and CRA development, SOP development and CRA management. She began her career in nursing and became involved in clinical research as a Study Coordinator. She has since accumulated over 20 years of multi-therapeutic clinical research experience in various capacities.
Jennifer Delaney, Associate Director, Contracts & Finance
Jennifer Delaney brings over 15 years of experience joining the MedSource team in 2007 where she currently leads our contracts and finance department in our Houston corporate office. Jennifer joined MedSource in 2007 and has various operational responsibilities which include overall management of finance and contracts, proposal and budget development, and identifying/integrating company technology systems. She has a broad background in the research industry including key roles in regulatory affairs and research laboratories. Jennifer graduated from the University of Houston Clear Lake with a BS in Biology and a MS in Biotechnology.
Marcia Phillips, Quality Assurance Manager
Marcia Phillips joined MedSource in September 2015 as the Quality Assurance Manager where she leads the Quality Assurance Department from our Raleigh office location. Marcia has over 20 years’ experience in regulated life science industry with a diverse background in Quality Assurance. Prior to MedSource, Marcia worked for several contract research organizations in the Research Triangle area where she developed a depth of knowledge in GxPs and their application to regulatory research and development. Her experience assists the MedSource team in delivering quality, compliant products and services to our clients.
She began her Quality Assurance career in the agrochemical industry before transitioning to preclinical pharmaceuticals, followed by clinical trial research. She received degrees from Pennsylvania State University (Wildlife Sciences), New Mexico State University (Wildlife Sciences with a Minor in Toxicology), and East Carolina University (History).